Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes

Cancer Research
Béatrice OrsettiCharles Theillet

Abstract

Chromosome 17 is severely rearranged in breast cancer. Whereas the short arm undergoes frequent losses, the long arm harbors complex combinations of gains and losses. In this work we present a comprehensive study of quantitative anomalies at chromosome 17 by genomic array-comparative genomic hybridization and of associated RNA expression changes by cDNA arrays. We built a genomic array covering the entire chromosome at an average density of 1 clone per 0.5 Mb, and patterns of gains and losses were characterized in 30 breast cancer cell lines and 22 primary tumors. Genomic profiles indicated severe rearrangements. Compiling data from all samples, we subdivided chromosome 17 into 13 consensus segments: 4 regions showing mainly losses, 6 regions showing mainly gains, and 3 regions showing either gains or losses. Within these segments, smallest regions of overlap were defined (17 for gains and 16 for losses). Expression profiles were analyzed by means of cDNA arrays comprising 358 known genes at 17q. Comparison of expression changes with quantitative anomalies revealed that about half of the genes were consistently affected by copy number changes. We identified 85 genes overexpressed when gained (39 of which mapped within the small...Continue Reading

References

Apr 1, 1997·Nature Genetics·F MitelmanB Johansson
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·R LiP Duesberg
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·K VirtanevaR Krahe
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·O MonniA Kallioniemi
Jun 20, 2002·Cancer Genetics and Cytogenetics·Stéphanie StruskiPascale Cornillet-Lefebvre
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Franck BorelRobert L Margolis
Sep 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jonathan R PollackPatrick O Brown

❮ Previous
Next ❯

Citations

Jan 27, 2009·Breast Cancer Research and Treatment·Alan MackayAlan Ashworth
Feb 16, 2006·Molecular and Cellular Biology·Mélanie FrancoSerge Roche
Jan 1, 2009·Advances in Bioinformatics·Nirmalya BandyopadhyaySanjay Ranka
Jan 25, 2006·BMC Cancer·Pia VahteristoHeli Nevanlinna
Jan 19, 2006·Breast Cancer Research : BCR·Ashleen Shadeo, Wan L Lam
Jul 5, 2006·Breast Cancer Research : BCR·Erik H van Beers, Petra M Nederlof
Mar 22, 2012·Breast Cancer Research : BCR·Rachael NatrajanJorge S Reis-Filho
Feb 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Itziar SalaverriaElias Campo
Jun 10, 2010·Future Oncology·Kai-Keen ShiuJorge S Reis-Filho
Jan 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicola CrestiAlan V Boddy
May 10, 2015·The Journal of Molecular Diagnostics : JMD·Vladimira KoudelakovaMarian Hajduch
Feb 24, 2016·Nature Communications·Clément ChevalierChristine Benistant
Nov 8, 2014·Neoplasia : an International Journal for Oncology Research·Ariadna TibauDaniel Escuin
Feb 5, 2010·The Journal of Investigative Dermatology·Elodie LaharanneJean-Philippe Merlio
Sep 1, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Luisa ErcolaniBenedetto Grimaldi
Feb 8, 2007·Genes, Chromosomes & Cancer·Anna L PatersonPaul A W Edwards
Jan 25, 2012·Chemical Biology & Drug Design·Douglas E FriesenJack A Tuszynski
Aug 4, 2009·Journal of Cellular Physiology·Christos D KatsetosPavel Dráber
Nov 11, 2014·Oncogene·A Emelyanov, D V Bulavin
Sep 22, 2016·Molecular & Cellular Oncology·Clément ChevalierChristine Bénistant
Jun 2, 2014·Current Opinion in Pharmacology·Lynne J Hocking, Fernando Rivadeneira
Apr 10, 2017·Cancer Chemotherapy and Pharmacology·Yong-Qiang RenYan-Bing Liu
Nov 23, 2006·British Journal of Cancer·P R BenusiglioB A J Ponder
Mar 12, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Edurne ArriolaJorge S Reis-Filho
Jun 27, 2006·Oncogene·S Camilleri-BroëtC H Régnier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.